Hi Timber the problem is as one investor who spoke out at the AGM said that Clover SUCKS at giving any meaningful forward guidance
So here are the salient points from questions asked at AGM yesterday that were not in PPT.
1. Since October 2014 8 new additional new customers were sgned wth substantial orders 2nd half of 2016
2. Existing customers pre Fonterra debacle have now all returned to the ordering books with one major doubling their order just announced at the meetng
3. Recent sales have seen an increase to higher margin products
4. The early orders for the recently installed spray drying plant in NZ has the plant running at full capacity from day one
5. China sales are up sgnicantly
6. Cash positioning is strong and growing
so 1-6 all good to stabilise the share price IMHO between 40-50 cents together with an improve dividend outlook
Then we turn our attention to the game changer being the results and outcome of the 7 year pre med trials which I have no clue what it would do to our share price if successful
Disclaimer : I own poster 3.7m shares
CLV Price at posting:
40.5¢ Sentiment: Hold Disclosure: Held